Search Results
Mar 26, 2026, 15:02 ET Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
KD).
More news about: Glancy Prongay Wolke & Rotter LLP
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyndryl Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - KD
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-kyndryl-holdings-inc-of-class-action-lawsuit-and-upcoming-deadlines--kd-302725664.htmlSOURCE
More news about: Pomerantz LLP
Mar 25, 2026, 09:00 ET April 13, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KD
March 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 17:25 ET KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the
More news about: THE ROSEN LAW FIRM, P. A.
Mar 24, 2026, 14:26 ET KD ALERT: New Kyndryl (KD) Securities Class Action Complaint Expands Class Period to August 1, 2024- Hagens Berman
shareholder rights law firm Hagens Berman is alerting investors to an expanded securities class action filed against Kyndryl Holdings, Inc. (NYSE: KD). The new litigation expands the potential class of affected investors and introduces new allegations regarding the company's free cash flow reporting.
More news about: Hagens Berman Sobol Shapiro LLP
Mar 24, 2026, 09:00 ET KD Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in Kyndryl Holdings, Inc. Securities Class Action Lawsuit -- The Gross Law Firm
March 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyndryl Holdings, Inc. (NYSE: KD).
More news about: The Gross Law Firm
Mar 23, 2026, 16:40 ET Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
KD). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYNDRYL HOLDINGS, INC. (KD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 13, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Mar 23, 2026, 08:00 ET Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa
https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products3 Frick KD, Roebuck MC, Feldstein JI, McCarty CA, Grover LL. Health services utilization and cost of retinitis pigmentosa. Arch Ophthalmol. 2012;130(5):629-634.
More news about: Sumitomo Pharma America
Mar 22, 2026, 09:14 ET KD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Kyndryl (KD) Investors of Securities Class Action Deadline on April 13, 2026
LLP, a leading national securities law firm, is investigating potential claims against Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 21, 2026, 11:53 ET Kyndryl Holdings, Inc. (KD) Class Action Lawsuit: Investors Face April 13, 2026, Deadline
Did you buy KD securities between August 1, 2024, and February 9, 2026?Affected Kyndryl Holdings, Inc. Investor SummaryWho: Kyndryl Holdings, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 20, 2026, 22:37 ET Kyndryl Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Kyndryl Holdings, Inc. - KD
Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD), if they purchased or otherwise acquired the Company's shares between August 1, 2024 and February 9, 2026, inclusive (the "Class Period"). These actions
More news about: ClaimsFiler
Mar 20, 2026, 16:29 ET KD INVESTOR ALERT: New Kyndryl (KD) Securities Class Action Complaint Expands Class Period to August 1, 2024- Hagens Berman
shareholder rights law firm Hagens Berman is alerting investors to an expanded securities class action filed against Kyndryl Holdings, Inc. (NYSE: KD). The new litigation expands the potential class of affected investors and introduces new allegations regarding the company's free cash flow reporting.
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 07:35 ET Mit RiboPepSTAR™ geht Ribo über die Leber hinaus - und ermöglicht so den gezielten Transport von siRNA in verschiedene Organe
Nieren Präklinische Studien mit RiboPepSTAR™ zeigen eine selektive Aufnahme in proximalen Tubuluszellen in verschiedenen Modellen, und es wurde ein Knockdown (KD) des Zielgens von bis zu 80 % erreicht, von Nagetieren bis hin zu nicht-menschlichen Primaten (NHPs). Der physiologische Proof of Concept wurde in mehreren
More news about: Suzhou Ribo Life Science Co., Ltd.
Mar 20, 2026, 03:18 ET Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs
targeting Using RiboPepSTAR™, preclinical studies demonstrate selective uptake in proximal tubular cells across models, and up to 80% target gene knockdown (KD) has been achieved, from rodents to NHPs. Physiological proof of concept was further validated in several disease models, such as type 2 diabetes model,
More news about: Suzhou Ribo Life Science Co., Ltd.
Mar 20, 2026, 03:17 ET Kyndryl Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KD
KD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of KD during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 20, 2026, 02:41 ET Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs
targeting Using RiboPepSTAR™, preclinical studies demonstrate selective uptake in proximal tubular cells across models, and up to 80% target gene knockdown (KD) has been achieved, from rodents to NHPs. Physiological proof of concept was further validated in several disease models, such as type 2 diabetes model,
More news about: Suzhou Ribo Life Science Co., Ltd.
Mar 20, 2026, 02:10 ET KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
KD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 19, 2026, 19:51 ET KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the
More news about: THE ROSEN LAW FIRM, P. A.
Mar 19, 2026, 14:55 ET Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
KD) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 19, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyndryl Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - KD
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-kyndryl-holdings-inc-of-class-action-lawsuit-and-upcoming-deadlines--kd-302717125.htmlSOURCE
More news about: Pomerantz LLP
Mar 18, 2026, 11:34 ET Kyndryl Holdings (KD) Faces Securities Class Action Amid 55% Stock Drop After Four Bombshell Disclosures - Hagens Berman
KD Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 18, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Kyndryl Holdings, Inc. (NYSE: KD) and seeks
More news about: Hagens Berman Sobol Shapiro LLP
Mar 18, 2026, 09:00 ET Kyndryl Holdings, Inc. Class Action: Levi & Korsinsky Reminds Kyndryl Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026 - KD
March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 18, 2026, 07:53 ET CHIPOTLE LAUNCHES FRESH CILANTRO LIME SAUCE FOR A LIMITED TIME AMID AMERICA'S SAUCE OBSESSION
https://www.dropbox.com/scl/fo/k91hmfzdwyzmy0eheitwp/AKgfwVfHREbzl3y7O3yhUBg?rlkey=hyhuvlsgkxh753qt8f4fo42kd&st=eqbc2qwk&dl=0"A flavorful sauce made fresh daily in our restaurants can completely change
More news about: Chipotle Mexican Grill, Inc.
Mar 17, 2026, 16:30 ET KD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Kyndryl (KD) Investors of Securities Class Action Deadline on April 13, 2026
LLP, a leading national securities law firm, is investigating potential claims against Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 17, 2026, 09:00 ET KD Shareholder Alert: Kyndryl Holdings, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyndryl Holdings, Inc. (NYSE: KD).
More news about: The Gross Law Firm